Development of a Joint Prediction Model Based on Both the Radiomics and Clinical Factors for Predicting the Tumor Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer

References

• Siegel RL, Miller KD, Jemal A, et al. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi:10.3322/caac.2159031912902
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller D, Fedewa SA, et al. Trends in colon and rectal cancer incidence in Australia from 1982 to 2014: analysis of data on over 375,000 cases. Cancer Epidemiol Biomarkers Prev. 2019;28(1):83–90. doi:10.1158/1055-9965.EPI-18-052330530848
   PubMed Web of Science ®Google Scholar
• Bailey CE, Hu CY, You YN, et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975–2010. JAMA Surg. 2015;150(1):17–22. doi:10.1001/jamasurg.2014.175625372703
   PubMed Web of Science ®Google Scholar
• Li Y, Wang J, Ma X, et al. A review of neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Int J Biol Sci. 2016;12(8):1022–1031. doi:10.7150/ijbs.1543827489505
   PubMed Web of Science ®Google Scholar
• Maas M, Nelemans PJ, Valentini V, et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol. 2010;11(9):835–844. doi:10.1016/S1470-2045(10)70172-820692872
   PubMed Web of Science ®Google Scholar
• Smith JJ, Garcia-Aguilar J. Advances and challenges in treatment of locally advanced rectal cancer. J Clin Oncol. 2015;33(16):1797–1808. doi:10.1200/JCO.2014.60.105425918296
   PubMed Web of Science ®Google Scholar
• Sanghera P, Wong DW, McConkey CC, et al. Chemoradiotherapy for rectal cancer: an updated analysis of factors affecting pathological response. Clin Oncol. 2008;20(2):176–183. doi:10.1016/j.clon.2007.11.013
   PubMed Web of Science ®Google Scholar
• Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med. 2006;355(11):1114–1123. doi:10.1056/NEJMoa06082916971718
   PubMed Web of Science ®Google Scholar
• van Gijn W, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 2011;12(6):575–582. doi:10.1016/S1470-2045(11)70097-321596621
   PubMed Web of Science ®Google Scholar
• Dhadda AS, Dickinson P, Zaitoun AM, et al. Prognostic importance Mandard tumour regression grade following pre-operative chemoradiotherapy locally advanced rectal cancer. Cancer. 2011;47(8):1138–1145.
   Web of Science ®Google Scholar
• Suarez J, Vera R, Balen E, et al. Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer. Colorectal Dis. 2008;10(6):563–568. doi:10.1111/j.1463-1318.2007.01424.x18070184
   PubMed Web of Science ®Google Scholar
• Dayde D, Tanaka I, Jain R, et al. Predictive and prognostic molecular biomarkers for response to neoadjuvant chemoradiation in rectal cancer. Int J Mol Sci. 2017;18(3):573. doi:10.3390/ijms18030573
   PubMed Web of Science ®Google Scholar
• Guillem JG, Ruby JA, Leibold T, et al. Neither FDG-PET Nor CT can distinguish between a pathological complete response and an incomplete response after neoadjuvant chemoradiation in locally advanced rectal cancer: a prospective study. Ann Surg. 2013;258(2):289–295. doi:10.1097/SLA.0b013e318277b62523187748
   PubMed Web of Science ®Google Scholar
• Horvat N, Carlos Tavares Rocha C, Clemente Oliveira B, et al. MRI of rectal cancer: tumor staging, imaging techniques, and management. Radiographics. 2019;39(2):367–387. doi:10.1148/rg.201918011430768361
   PubMed Web of Science ®Google Scholar
• Jhaveri KS, Hosseini-Nik H. MRI of rectal cancer: an overview and update on recent advances. AJR Am J Roentgenol. 2015;205(1):W42–55. doi:10.2214/AJR.14.1420126102418
   PubMed Web of Science ®Google Scholar
• Gollub MJ, Blazic I, Felder S, et al. Value of adding dynamic contrast-enhanced MRI visual assessment to conventional MRI and clinical assessment in the diagnosis of complete tumour response to chemoradiotherapy for rectal cancer. Eur Radiol. 2019;29(3):1104–1113. doi:10.1007/s00330-018-5719-130242504
   PubMed Web of Science ®Google Scholar
• Martens MH, Maas M, Heijnen LA, et al. Long-term outcome of an organ preservation program after neoadjuvant treatment for rectal cancer. J Natl Cancer Inst. 2016;108(12):djw171. doi:10.1093/jnci/djw17127509881
   PubMedGoogle Scholar
• Maas M, Beets-Tan RG, Lambregts DM, et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol. 2011;29(35):4633–4640. doi:10.1200/JCO.2011.37.717622067400
   PubMed Web of Science ®Google Scholar
• van der Valk MJM, Hilling DE, Bastiaannet E, et al. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet. 2018;391(10139):2537–2545. doi:10.1016/S0140-6736(18)31078-X29976470
   PubMed Web of Science ®Google Scholar
• Smith JJ, Strombom P, Chow OS, et al. Assessment of a Watch-and-Wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy. JAMA Oncol. 2019;5(4):e185896. doi:10.1001/jamaoncol.2018.589630629084
   PubMed Web of Science ®Google Scholar
• Ryan JE, Warrier SK, Lynch AC, et al. Predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review. Colorectal Dis. 2016;18(3):234–246. doi:10.1111/codi.1320726531759
   PubMed Web of Science ®Google Scholar
• Aerts HJ, Velazquez ER, Leijenaar RT, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat. Commun. 2014;5(1):4006. doi:10.1038/ncomms500624892406
   PubMed Web of Science ®Google Scholar
• Lambin P, Leijenaar RTH, Deist TM, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14(12):749–762. doi:10.1038/nrclinonc.2017.14128975929
   PubMed Web of Science ®Google Scholar
• Thawani R, McLane M, Beig N, et al. Radiomics and radiogenomics in lung cancer: a review for the clinician. Lung Cancer. 2018;115:34–41. doi:10.1016/j.lungcan.2017.10.01529290259
   PubMed Web of Science ®Google Scholar
• Valdora F, Houssami N, Rossi F, et al. Rapid review: radiomics and breast cancer. Breast Cancer Res Treat. 2018;169(2):217–229. doi:10.1007/s10549-018-4675-429396665
   PubMed Web of Science ®Google Scholar
• Huang YQ, Liang CH, He L, et al. Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol. 2016;34(18):2157–2264. doi:10.1200/JCO.2015.65.912827138577
   PubMed Web of Science ®Google Scholar
• Horvat N, Veeraraghavan H, Khan M, et al. MR imaging of rectal cancer: radiomics analysis to assess treatment response after neoadjuvant therapy. Radiology. 2018;287(3):833–843. doi:10.1148/radiol.201817230029514017
   PubMed Web of Science ®Google Scholar
• Yi X, Pei Q, Zhang Y, et al. MRI-based radiomics predicts tumor response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Front Oncol. 2019;9:552. doi:10.3389/fonc.2019.0055231293979
   PubMed Web of Science ®Google Scholar
• Nie K, Shi L, Chen Q, et al. Rectal cancer: assessment of neoadjuvant chemoradiation outcome based on radiomics of multiparametric MRI. Clin Cancer Res. 2016;22(21):5256–5264. doi:10.1158/1078-0432.CCR-15-299727185368
   PubMed Web of Science ®Google Scholar
• Alvarez-Jimenez C, Antunes JT, Talasila N, et al. Radiomic texture and shape descriptors of the rectal environment on post-chemoradiation T2-weighted MRI are associated with pathologic tumor stage regression in rectal cancers: a Retrospective, Multi-Institution Study. Cancers (Basel). 2020;12(8):2027. doi:10.3390/cancers12082027
   PubMed Web of Science ®Google Scholar
• Liu Z, Zhang XY, Shi YJ, et al. Radiomics analysis for evaluation of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Clin Cancer Res. 2017;23(23):7253–7262. doi:10.1158/1078-0432.CCR-17-103828939744
   PubMed Web of Science ®Google Scholar
• Kalisz KR, Enzerra MD, Paspulati RM. MRI evaluation of the response of rectal cancer to neoadjuvant chemoradiation therapy. Radiographics. 2019;39(2):538–556. doi:10.1148/rg.201918007530844347
   PubMed Web of Science ®Google Scholar
• Hosny A, Parmar C, Quackenbush J, et al. Artificial intelligence in radiology. Nat Rev Cancer. 2018;18(8):500–510. doi:10.1038/s41568-018-0016-529777175
   PubMed Web of Science ®Google Scholar
• Bulens P, Couwenberg A, Intven M, et al. Predicting the tumor response to chemoradiotherapy for rectal cancer: model development and external validation using MRI radiomics. Radiother Oncol. 2020;142:246–252. doi:10.1016/j.radonc.2019.07.03331431368
   PubMed Web of Science ®Google Scholar
• Cui Y, Yang X, Shi Z, et al. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Eur Radiol. 2019;29(3):1211–1220. doi:10.1007/s00330-018-5683-930128616
   PubMed Web of Science ®Google Scholar
• Pham TT, Liney G, Wong K, et al. Study protocol: multi-parametric magnetic resonance imaging for therapeutic response prediction in rectal cancer. BMC Cancer. 2017;17(1):465. doi:10.1186/s12885-017-3449-428676107
   PubMed Web of Science ®Google Scholar
• Armbruster M, D’Anastasi M, Holzner V, et al. Improved detection of a tumorous involvement of the mesorectal fascia and locoregional lymph nodes in locally advanced rectal cancer using DCE-MRI. Int J Colorectal Dis. 2018;33(7):901–909. doi:10.1007/s00384-018-3083-x29774398
   PubMed Web of Science ®Google Scholar
• Iannicelli E, Di Renzo S, Ferri M, et al. Accuracy of high-resolution MRI with lumen distention in rectal cancer staging and circumferential margin involvement prediction. Korean J Radiol. 2014;15(1):37–44. doi:10.3348/kjr.2014.15.1.3724497790
   PubMed Web of Science ®Google Scholar
• Kang BM, Park YK, Park SJ, et al. Does circumferential tumor location affect the circumferential resection margin status in mid and low rectal cancer? Asian J Surg. 2018;41(3):257–263. doi:10.1016/j.asjsur.2016.12.00128118954
   PubMed Web of Science ®Google Scholar
• van der Paardt MP, Zagers MB, Beets-Tan RG, et al. Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging: a systematic review and meta-analysis. Radiology. 2013;269(1):101–112. doi:10.1148/radiol.1312283323801777
   PubMed Web of Science ®Google Scholar
• Lech G, Słotwiński R, Słodkowski M, et al. Colorectal cancer tumour markers and biomarkers: recent therapeutic advances. World J Gastroenterol. 2016;22(5):1745–1755. doi:10.3748/wjg.v22.i5.174526855534
   PubMed Web of Science ®Google Scholar